VanEck Associates’s 1Life Healthcare ONEM Stock Holding History

VanEck Associates’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,423	Closed	-$57K	–	1456
2022 Q4	$57K	Buy	3,423 +1,210	+55%	+$20.4K	﹤0.01%	1304
2022 Q3	$38K	Buy	+2,213	New	+$34.7K	﹤0.01%	1285

VanEck Associates's ONEM Position: Q1 2023 in Review

VanEck Associates sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 3,423 shares — an estimated $57K sold.

VanEck Associates first reported a position in ONEM in Q3 2022 and held it in 2 quarters. The position peaked at $57K in Q4 2022. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

VanEck Associates reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
VanEck Associates sold 3,423 1Life Healthcare shares in Q1 2023, an estimated $57K.
VanEck Associates first reported a position in 1Life Healthcare in Q3 2022 and held it in 2 quarters.
VanEck Associates's 1Life Healthcare position peaked at $57K in Q4 2022.
0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on VanEck Associates's 13F filing for Q1 2023, filed 3 May 2023.